Enzo Life Sciences is proud to introduce our newest immunoassay, IL-6 (human), high sensitivity ELISA kit, the most sensitive IL-6 ELISA on the market. Enzo’s new kit is able to detect IL-6 levels down to 0.057 pg/mL. In addition, our kit offers detection in 3 hours, with liquid color-coded reagents that reduce the possibility for error. From forty years of manufacturing, Enzo’s immunoassays offer high precision, accuracy, sensitivity, and specificity.
IL-6 is a cytokine critical to the regulation of the immune and hematopoietic systems, usually expressed by T-cells, mast cells, monocytes, macrophages, fibroblasts, endothelial cells, keratinocytes, and many tumor cell lines. It plays a role in acute phase reactions and response to injury and inflammation. Human IL-6 also stimulates the differentiation of B-cells for antibody production, promotes expansion of activated T-cells, expands hematopoietic cell production, and induces the expression of acute phase proteins.
IL-6 (human), high sensitivity ELISA kit is the latest in Enzo’s line of cost-effective, highly adaptable, and high performance products and kits. This assay represents another addition to Enzo’s considerable portfolio of immunology products, including Cytokine and Eicosanoid ELISAs, CD Marker Antibodies, and Live Cell Analysis kits for Multidrug Resistance.
Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and therapeutics through the development of unique diagnostic platform technologies. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products and services that meet the ever-changing and rapidly growing needs of healthcare. Underpinning Enzo Biochem’s technologies, platforms and products is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.
Enzo Life Sciences, Inc. is a pioneer in labeling and detection technologies from genome to whole cell across research and diagnostic markets. We are focused on providing cost-effective, relevant and reliable solutions for life science research, drug development, and clinical research. We are organized to lead in the development, production, marketing, and sales of innovative research tools worldwide based on 40 years’ experience in building strong global market recognition and implementing outstanding operational capabilities.
New Product Release
Date: November 2nd 2016
For additional Information, please contact:
Kara Cannon, Global Head of Marketing
1-631-694-7070 x 1301
